Titan Medical Inc (TMDIF)

[66Mustang]

I do agree that the schedule posted in the June Short Form Prospectus looks like it should be fairly easy for Titan to achieve. They projected FDA submission Q4 2018 and approval H1 2019.

Another interesting reminder: Transenterix placed a Senhance system at Nicholson weeks after ours. They are behind our schedule with regard to development of training programs for the US market; their only advantage is that they must have some sort of training program for Europe to leverage. Also, the systems used to have four giant pods crowding the patient bed, with one little arm per pod. The FDA only approved a three-armed system for use in the US. I wonder why they had to scale it back.